Advances in both light and electron microscopy are improving scientists' ability to visualize viruses such as HIV, respiratory syncytial virus (RSV), measles, influenza, and Zika in their native states. Researchers from Emory ...
Cell & Microbiology
Jan 6, 2017
0
67
New antiviral materials made from sugar have been developed to destroy viruses on contact and may help in the fight against viral outbreaks.
Biochemistry
Jan 29, 2020
0
993
Scientists in the US have developed a novel vaccination method that uses tiny gold particles to mimic a virus and carry specific proteins to the body's specialist immune cells.
Bio & Medicine
Jun 25, 2013
0
0
Researchers at the University of Leeds are developing a way to 'barcode' viral diseases to rapidly test new outbreaks for potentially lethal mutations.
Cell & Microbiology
May 13, 2012
0
0
Viral infections kill millions of people worldwide every year, but currently available antiviral drugs are limited in that they mostly act against one or a small handful of related viruses. A few broad-spectrum drugs that ...
Bio & Medicine
Dec 18, 2017
0
82
New lung "organoids"—tiny 3-D structures that mimic features of a full-sized lung—have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC). The team used the organoids ...
Cell & Microbiology
May 12, 2017
0
201
By the time they're two, most children have had respiratory syncytial virus (RSV) and suffered symptoms no worse than a bad cold. But for some children, especially premature babies and those with underlying health conditions, ...
Bio & Medicine
Dec 30, 2013
0
0
Northwestern University researchers have, for the first time, determined the 3-D atomic structure of a key complex in paramyxoviruses, a family of viruses that includes measles, mumps, human parainfluenza and respiratory ...
Cell & Microbiology
Feb 17, 2020
0
286
By figuring out how a common virus hides from the immune system, scientists have identified a potential vaccine to prevent sometimes deadly respiratory infections in humans.
Cell & Microbiology
Feb 3, 2020
0
363
Human cells use a protein named TBC1D5 to route influenza A viruses inside host cells for destruction, preventing the virus from spreading replicated copies of itself to other cells, according to a study published in Nature ...
Cell & Microbiology
Oct 29, 2021
0
83
Human respiratory syncytial virus (RSV) causes respiratory tract infections. It is the major cause of lower respiratory tract infection and hospital visits during infancy and childhood. There is no vaccine, and the only treatment is oxygen.
In temperate climates there is an annual epidemic during the winter months. In tropical climates, infection is most common during the rainy season.
In the United States, 60% of infants are infected during their first RSV season, and nearly all children will have been infected with the virus by 2-3 years of age. Natural infection with RSV does not induce protective immunity, and thus people can be infected multiple times. Sometimes an infant can become symptomatically infected more than once even within a single RSV season. Severe RSV infections have increasingly been found among elderly patients.
RSV is a negative-sense, single-stranded RNA virus of the family Paramyxoviridae, which includes common respiratory viruses such as those causing measles and mumps. RSV is a member of the paramyxovirus subfamily Pneumovirinae. Its name comes from the fact that F proteins on the surface of the virus cause the cell membranes on nearby cells to merge, forming syncytia.
This text uses material from Wikipedia, licensed under CC BY-SA
